Bionor Pharma ASA | Balance Sheet
Fiscal year is January-December. All values NOK Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
108
93
11
239
351
578
Net Property, Plant & Equipment
3
2
4
204
3
4
Total Assets
197
187
97
1,833
2,138
3,328
Deferred Taxes
-
-
-
36
34
Other Liabilities
17
27
31
252
359
Total Liabilities
17
27
31
1,322
1,624
Common Equity (Total)
180
160
66
497
510
Total Shareholders' Equity
180
160
66
497
510
Total Equity
180
160
66
511
514
Liabilities & Shareholders' Equity
197
187
97
1,833
2,138
Accumulated Minority Interest
-
-
-
14
4
Short-Term Receivables
3
20
22
100
86
7
Other Assets (Including Intangibles)
84
72
62
1,289
1,697
2,737
Investment in Unconsolidated Subs.
-
-
-
2
-
-
Total Debt
-
-
-
1,034
1,231
About Bionor Pharma ASA
View Profile
